Dr Sandeep Satsangi
Senior Consultant Hepatologist & Liver Transplant Physician
Liver Transplant Doctor in Bannerghatta
Dr Sandeep Satsangi
Dr Sandeep Satsangi is one of the leading Hepatologists and Liver Transplant Specialists based in Bangalore, with a thriving experience of over 10 years in the field. As a dedicated professional, he is utterly passionate about his profession and is always ready to serve his patients.
Dr Sandeep passed MD Internal Medicine from Kasturba Medical College, Mangalore. He was awarded the best outgoing student and was the University Topper. Subsequently pursued DM in Hepatology from Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. Dr Sandeep Satsangi has been extensively trained in the field of Liver diseases and Liver transplantation. Dr Sandeep has a positive attitude towards work and great ability towards result-oriented output. He demonstrates excellent communication/ interpersonal skills to interact with individuals at all levels. He is the best liver transplant doctor in Bannerghatta and he can give you the best treatment for liver problems. Visit him today.
Dr Sandeep Satsangi is a part of a team which has successfully completed 200 liver transplants (first in Karnataka). He served as Assistant Editor of Journal of Clinical and Experimental Hepatology from 2016-17 which is International Peer Reviewed Journal.
Dr Sandeep believes in teamwork. He works in close association with hepatobiliary surgeons, critical care specialists, and transplant anaesthetists. The dedicated team increases productivity and patient care. Dr Sandeep Satsangi is recognised nationally for his expertise in providing comprehensive medical care to patients suffering from a liver ailment. Visit him today as he is the best liver transplant doctor in Bannerghatta.
For appointments please call us on: +91 87926 62236
Liver Transplant Doctor in Bannerghatta
EDUCATION
- MBBS from MNR Medical College &Hospital, Sangareddy, Telangana, India.
- MD, Internal Medicine from Kasturba Medical College, Mangalore (Manipal University), Karnataka, India.
- DM 'Hepatology' from PGIMER, Chandigarh, India.
Awards & Achievements
- MBBS: The distinction in subjects - Pharmacology, Ophthalmology, Microbiology, Social and Preventive Medicine, Paediatrics.
- M.D - Internal Medicine: - Best outgoing student and UNIVERSITY topper 2011 MD batch. - First rank in Cardiology-Respiratory medicine exam. - First prize in the MD intercollegiate quiz competition (2013) held at Cochin, India.
- DM - Hepatology: - Topped D.M Hepatology exam held at PGI, Chandigarh in December 2016. - Served as the Assistant Editor of Journal of Clinical and Experimental Hepatology from July 2016 to July 2017 which is an International Peer-reviewed journal of Hepatology.
- (Received formal training in EVISE system) Actively assisted Prof. R.K Dhiman who is the ‘Secretary-General, Indian National Association for Study of the Liver (INASL) and Past President, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
Poster Presentations
- At AASLD 2016- Boston 'Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)'
- At INASL - 2015 (New- Delhi) 'Small intestinal bacterial overgrowth and toll-like receptor signalling in patients with nonalcoholic fatty liver disease'
- At INASL - 2016 (New-Delhi)
- Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis
- Surveillance regarding prevention and care of Hepatitis B Virus (HBV) positive patients amongst the nurses
- At INASL 2018 (New-Delhi) Khat related chronic liver disease: An under-recognised entity!
PAPERS AND PRESENTATIONS
Oral presentations
- Oral Paper presentation at ISGCON 2016 held at New Delhi. ‘Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)' Received FIRST prize in the plenary session for the best paper award.
- Oral paper presentation at APASL- SINGLE THEME CONFERENCE- HCV Infection and Disease & Recent Advances in Liver Diseases - 2015 (New-Delhi)' Oral treatment with sofosbuvir plus ribavirin is preferred over interferon-based triple therapy in patients with chronic hepatitis C.'
- Oral paper presentation at 3rd International Liver symposium - 2016 (New-Delhi) 'Transient elastography is inaccurate in assessing hepatic fibrosis in patients with end-stage renal disease and chronic hepatitis C'- Selected in the Top 5 papers and awarded a prize.
Publications
Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019
Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018. 6) Satsangi S. Post-Paracentesis Hemoperitoneum – Time to Become More Careful! Liver Int. 2018
Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It’s all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018
Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease – A Randomized Controlled Trial. J Gastroenterol Hepatol Open 2017.
Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232
Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla.
(Association of physicians of India ‘Medicine update’ 2015)Recent advances in the medical management of portal hypertension. Sandeep Satsangi, Yogesh. K Chawla.
(Association of physicians of India ‘Medicine update’ 2016)How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla.
(Progress in Gastroenterology & Hepatology 2015)Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
Acute-on chronic liver failure – The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.